Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients (original) (raw)

• Robbins, P.F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747–752 (2013).
  Article CAS Google Scholar
• Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neoantigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81–85 (2015).
  Article CAS Google Scholar
• Gros, A. et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246–2259 (2014).
  Article CAS Google Scholar
• Rosenberg, S.A. et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J. Am. Med. Assoc. 271, 907–913 (1994).
  Article CAS Google Scholar
• Rosenberg, S.A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T cell–transfer immunotherapy. Clin. Cancer Res. 17, 4550–4557 (2011).
  Article CAS Google Scholar
• Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti–PD-1) in melanoma. N. Engl. J. Med. 369, 134–144 (2013).
  Article CAS Google Scholar
• Larkin, J. et al. Combined nivolumab and ipilimumab, or monotherapy, in untreated melanoma. N. Engl. J. Med. 373, 23–34 (2015).
  Article Google Scholar
• Postow, M.A. et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006–2017 (2015).
  Article Google Scholar
• Topalian, S.L. et al. Survival, durable tumor remission and long-term safety in patients with advanced melanoma receiving nivolumab. J. Clin. Oncol. 32, 1020–1030 (2014).
  Article CAS Google Scholar
• Alexandrov, L.B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
  Article CAS Google Scholar
• Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).
  Article CAS Google Scholar
• Rizvi, N.A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small-cell lung cancer. Science 348, 124–128 (2015).
  Article CAS Google Scholar
• Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189–2199 (2014).
  Article Google Scholar
• Le, D.T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509–2520 (2015).
  Article CAS Google Scholar
• Lu, Y.C. et al. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin. Cancer Res. 20, 3401–3410 (2014).
  Article CAS Google Scholar
• Tran, E. et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344, 641–645 (2014).
  Article CAS Google Scholar
• Carreno, B.M. et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 348, 803–808 (2015).
  Article CAS Google Scholar
• Schumacher, T.N. & Schreiber, R.D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).
  Article CAS Google Scholar
• Rosenberg, S.A. & Restifo, N.P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).
  Article CAS Google Scholar
• van Rooij, N. et al. Tumor-exome analysis reveals neoantigen-specific T cell reactivity in an ipilimumab-responsive melanoma. J. Clin. Oncol. 31, e439–e442 (2013).
  Article Google Scholar
• Cohen, C.J. et al. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J. Clin. Invest. 125, 3981–3991 (2015).
  Article Google Scholar
• Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).
  Article CAS Google Scholar
• Lennerz, V. et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. USA 102, 16013–16018 (2005).
  Article CAS Google Scholar
• Ahmadzadeh, M. et al. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537–1544 (2009).
  Article CAS Google Scholar
• Baitsch, L. et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350–2360 (2011).
  Article CAS Google Scholar
• Inozume, T. et al. Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells. J. Immunother. 33, 956–964 (2010).
  Article CAS Google Scholar
• Linnemann, C. et al. High-throughput identification of antigen-specific TCRs by TCR gene capture. Nat. Med. 19, 1534–1541 (2013).
  Article CAS Google Scholar
• Van Allen, E.M. et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat. Med. 20, 682–688 (2014).
  Article CAS Google Scholar
• Lee, H.B. et al. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens. Cancer Cytopathol. 123, 669–677 (2015).
  Article CAS Google Scholar
• Murtaza, M. et al. Noninvasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).
  Article CAS Google Scholar
• Lohr, J.G. et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat. Biotechnol. 32, 479–484 (2014).
  Article CAS Google Scholar
• Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
  Article CAS Google Scholar
• Trapnell, C. et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
  Article CAS Google Scholar
• Wu, T.C. et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA 92, 11671–11675 (1995).
  Article CAS Google Scholar
• Bai, Y., Ni, M., Cooper, B., Wei, Y. & Fury, W. Inference of high-resolution HLA types using genome-wide RNA- or DNA-sequencing reads. BMC Genomics 15, 325 (2014).
  Article Google Scholar
• Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43, D405–D412 (2015).
  Article CAS Google Scholar
• Nielsen, J.S., Wick, D.A., Tran, E., Nelson, B.H. & Webb, J.R. An _in vitro_–transcribed mRNA polyepitope construct encoding 32 distinct HLA class I–restricted epitopes from CMV, EBV and influenza for use as a functional control in human immune-monitoring studies. J. Immunol. Methods 360, 149–156 (2010).
  Article CAS Google Scholar
• Cohen, C.J., Zhao, Y., Zheng, Z., Rosenberg, S.A. & Morgan, R.A. Enhanced antitumor activity of murine-human hybrid T cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res. 66, 8878–8886 (2006).
  Article CAS Google Scholar
• Cohen, C.J. et al. Enhanced antitumor activity of T cells engineered to express T cell receptors with a second disulfide bond. Cancer Res. 67, 3898–3903 (2007).
  Article CAS Google Scholar
• Haga-Friedman, A., Horovitz-Fried, M. & Cohen, C.J. Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity. J. Immunol. 188, 5538–5546 (2012).
  Article CAS Google Scholar